about
Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrixTransglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and deathCellular functions of tissue transglutaminaseUsing FLIM-FRET to measure conformational changes of transglutaminase type 2 in live cellsScreening of substrate peptide sequences for tissue-type transglutaminase (TGase 2) using T7 phage cDNA library.Tissue transglutaminase-mediated glutamine deamidation of beta-amyloid peptide increases peptide solubility, whereas enzymatic cross-linking and peptide fragmentation may serve as molecular triggers for rapid peptide aggregationTGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing.Aberrant calcium signaling by transglutaminase-mediated posttranslational modification of inositol 1,4,5-trisphosphate receptorsTransglutaminase 2 exacerbates α-synuclein toxicity in mice and yeastType 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential.Transglutaminase 2 and phospholipase A₂ interactions in the inflammatory response in human Thp-1 monocytes.Stable isotope gas chromatography-tandem mass spectrometry determination of aminoethylcysteine ketimine decarboxylated dimer in biological samplesγ-Glutamylamines and neurodegenerative diseasesTransglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubulesTransglutaminase activation in neurodegenerative diseases.Measurement of sulfur-containing compounds involved in the metabolism and transport of cysteamine and cystamine. Regional differences in cerebral metabolism.Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.Potential of transglutaminase 2 as a therapeutic target.Evidences for a role of protein cross-links in transglutaminase-related disease.Transglutaminases and receptor tyrosine kinases.Autoimmune diseases and polyamines.Overlapped metabolic and therapeutic links between Alzheimer and diabetes.Transglutaminase 2 and neuroinflammation.Amphotericin B Increases Transglutaminase 2 Expression Associated with Upregulation of Endocytotic Activity in Mouse Microglial Cell Line BV-2.Transglutaminase 2 interaction with small heat shock proteins mediate cell survival upon excitotoxic stress.Modeling pathogenesis of Huntington's disease with inducible neuroprogenitor cells.A profiling platform for the characterization of transglutaminase 2 (TG2) inhibitors.SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's DiseaseIrreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.Calcium-dependent activation of transglutaminase 2 by nanosecond pulsed electric fields.Distribution of transglutaminase 6 in the central nervous system of adult mice.Transglutaminases: future perspectives.Inhibition of transglutaminase exacerbates polyglutamine-induced neurotoxicity by increasing the aggregation of mutant ataxin-3 in an SCA3 Drosophila model.Mutations in TGM6 induce the unfolded protein response in SCA35.Inspired by Nature: The 3-Halo-4,5-dihydroisoxazole Moiety as a Novel Molecular Warhead for the Design of Covalent Inhibitors.Understanding depression: linking brain-derived neurotrophic factor, transglutaminase 2 and serotonin.Uncovering protein polyamination by the spermine-specific antiserum and mass spectrometric analysis.
P2860
Q24309155-21748E5E-431C-4B9F-AAD0-50351FABA6A5Q28069852-6B4515CF-ADCF-4A44-ADFF-574EA56C4E85Q28260600-C22275B4-3D03-4387-8ADA-3E4EC463542AQ28483257-1D7E17C2-06C2-48BA-B038-CD4CF14D00DDQ33701867-E00BE43A-ABF5-4C74-9FD9-C47F9FCC9F4BQ33814180-AC952225-4836-434E-BC43-E963422BBF54Q34151711-B04DE4B4-73A1-45C8-A332-0C7070D64EB7Q34281322-6FE3E4A3-F2CA-46B0-AC6D-0838F352563EQ34365610-6143FED1-7DDE-46C7-A340-8DFF2EAF1CF4Q34775357-7D6676DB-32F1-4E76-ABC8-DA77CC0BDAD8Q34891892-7B1ADE5B-56D9-494F-A62D-7F1FC9F14495Q36291480-310BA37A-A5EA-44E8-B3C9-B2EEF802C312Q36377238-067CEA91-40E9-4E14-87B2-E9B8BAEFEDFDQ36768195-30F23744-B5CF-4DC4-8DE5-42E5584EC395Q37352964-217C4A77-7C24-4D25-BE6D-78EE7786F629Q37365038-0978DBD0-C790-4E85-A790-2B0FA80AF5A4Q37466088-69D6B9CE-8EDE-4F78-963C-D353F29C49C7Q37776508-F1622316-836F-4CB2-8704-2CEBE6FCC500Q37907975-51746335-7BE9-42BC-8AF4-CF47778A55FAQ37944145-7A1BF634-EF38-4B3F-9FEC-270E4C64A192Q37960864-8BF029C3-A404-4AB0-8F5E-4F3F2BF93112Q38046539-48C010C3-F2F1-45B0-AAFE-135216C6BA1BQ38268274-BAF7A622-39C4-4CB5-9732-829DCF3E4CA2Q38715410-1766E646-47A9-434C-81DD-CA335471541CQ39470547-CFEFE14C-9E1D-4FE7-9E80-8153AF4C87DAQ39567922-974D8997-9E6D-409A-8AC5-1EDED3F1C523Q39714317-0BE5FB18-1CFA-4BB4-BAFE-05EE23C5F965Q39731379-F9091E9C-1367-4C38-8E3B-24919FE773B5Q39733981-29C7DC4E-9EDE-424B-9628-F9177918348DQ40981694-6C5DB90C-41B5-49CA-AC4D-380CBC14D5A0Q42441119-290FD0B9-4EA4-4B8E-9532-A8E8EE35D30FQ44811427-2FCBDB3C-0B0E-4092-9364-3F67F7572B48Q47070607-86F83B11-D01D-4D09-BF2E-71F6650082F5Q47767397-0BD8078C-821C-4D6F-82A6-BC4BEE842899Q48098504-40610030-ADC4-4F8F-A42C-0E1AE1E7F90AQ48247681-3FFB853D-64AD-4136-8345-4227F22E0D7AQ53671776-EE39597A-D22B-4DF1-9A9B-7CFBB0353351
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transglutaminases and neurodegeneration.
@en
Transglutaminases and neurodegeneration.
@nl
type
label
Transglutaminases and neurodegeneration.
@en
Transglutaminases and neurodegeneration.
@nl
prefLabel
Transglutaminases and neurodegeneration.
@en
Transglutaminases and neurodegeneration.
@nl
P2093
P2860
P1476
Transglutaminases and neurodegeneration.
@en
P2093
Arthur J L Cooper
Boris F Krasnikov
John T Pinto
Mark Horswill
Thomas M Jeitner
P2860
P304
P356
10.1111/J.1471-4159.2009.05843.X
P407
P478
109 Suppl 1
P577
2009-05-01T00:00:00Z